All Notes

VITEK 2 Yeast AST System: Introduction, Name of Card, Principle, Procedure, Result-Interpretation, and Keynotes

Introducton

The VITEK 2 Yeast AST system is a fully automated solution for the quantitative determination of antifungal susceptibility in clinically significant yeasts, such as Candida species. It provides rapid and accurate results, often in as little as 13 to 24 hours.

Name of Card

  • AST-YS09: This is the primary card used for Yeast Susceptibility Testing.
Fig. VITEK 2 AST-YS08-Yeast Identification Card
  • ID-YST: Though not for AST, this card is often used in tandem for species-level identification of up to 63 types of yeast.

Principle

The system is based on the broth microdilution minimum inhibitory concentration (MIC) technique.

  • Miniaturization: The AST card is a miniaturized version of the doubling dilution technique, containing 64 microwells.
  • Growth Detection: It utilizes repetitive turbidimetric monitoring of fungal growth.
  • Optical Monitoring: The system monitors the attenuation of light in each well using an optical scanner (photometer) to determine the MIC based on the growth rate compared to a control well.

Procedure

The workflow is designed to be highly automated with minimal manual handling.

  1. Inoculum Preparation: Select morphologically similar, pure colonies from a primary culture (18–24 hours old).
  2. Standardization: Suspend the yeast in sterile saline (0.45% to 0.50% NaCl) to reach a turbidity of 1.80 to 2.20 McFarland, verified using the DensiCHEK instrument.
  3. Loading: Place the inoculum tube and AST card into the VITEK 2 Cassette.
  4. Automation: The instrument automatically fills the card (using a vacuum), seals it, and moves it to the incubator/reader module.
  5. Incubation: The card is incubated at 35.5°C, with optical readings taken every 15 minutes.

Result-Interpretation

  • MIC Determination: The system generates a report with the MIC value for each antifungal agent.
  • Breakpoints: Results are interpreted as Susceptible (S), Intermediate (I), or Resistant (R) based on integrated CLSI, EUCAST, or FDA guidelines.
PDF: AST YS08
  • Advanced Expert System (AES): Every result is cross-checked against a database of over 3,800 phenotypes to ensure biological consistency and identify specific resistance mechanisms.

Keynotes

  • Rapid Turnaround: Most yeast results are available within 13 to 27 hours, significantly faster than the 48-hour reference broth microdilution method.
  • Closed System: The sealed card format minimizes aerosols, spills, and personal contamination, reducing biohazardous waste by up to 80%.
Fig. Yeast Breakpoints
  • Inoculum Stability: The age of the suspension must not exceed 30 minutes before card inoculation.
  • Limitations: It may not be recommended for certain rare or difficult-to-grow species like Candida auris without specific validation, as results can be clade-dependent.

Further Readings

  1. https://medicallabnotes.com/vitek-2-compact-system-introduction-testing-requirements-testing-procedure-result-interpretation-and-keynotes/
  2. https://www.biomerieux.com/us/en/our-offer/clinical-products/vitek-2.html
  3. https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232967.pdf
  4. https://www.youtube.com/watch?v=ZsrxraVEGBU&t=13
  5. https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232967.pdf
  6. https://www.biomerieux.com/corp/en/our-offer/clinical-products/vitek-2.html
  7. https://eshop.biomerieux.com/s/product/astys09-test-kit-20-cards-423331/01t1p000006y2biAAA?language=en_US
  8. https://www.biomerieux.com/corp/en/our-offer/clinical-products/vitek-2-compact.html
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC5126752/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3958196/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC130656/
  12. https://biotek.com.mk/product/vitek-2-ast-cards/
  13. https://www.scielo.br/j/bjm/a/cbm8n9ZY9VgsSPCd4KBQMcB/?format=pdf&lang=en
Medical Lab Notes

Recent Posts

Acinetobacter baumannii complex-Introduction, Species in this group, Morphology, Pathogenicity, Lab Diagnosis, Treatment, Prevention, and Keynotes

Introduction The Acinetobacter baumannii complex (ABC) is a group of highly resilient, opportunistic Gram-negative bacteria…

13 hours ago

CRISPR/Cas9: Introduction, Application, and Keynotes

Introduction and  Mechanism CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. In nature, bacteria…

1 week ago

Foundation for Quality India (FQI): Introduction, Programs, Contact, and Keynotes

Introduction to FQI FQI specializes in training laboratory professionals to understand and implement strict quality…

1 week ago

TOP 10 Bacterial Diseases: Introduction, List, Pathogenicity, Lab Diagnosis, Treatment, Prevention, and Keynotes

Introduction to Bacterial Diseases Bacterial diseases are illnesses caused by pathogenic bacteria entering the body,…

3 weeks ago

HVAC Vs HEPA Filters: Introduction, Comparison, and Keynotes

Introduction The fundamental difference is that standard HVAC filters are primarily designed to protect heating…

4 weeks ago

HVAC Filters-Introduction, Principle, Working Mechanism, Application, and Keynotes

Introduction to HVAC Filters Air filters act as the first line of defense in an…

4 weeks ago